Notice of Closed Meeting, 2136 [2020-00372]
Download as PDF
<![CDATA[
2136
Federal Register / Vol. 85, No. 9 / Tuesday, January 14, 2020 / Notices
conducts independent reviews of the
cost of travel and the operation of
privately owned airplanes and
motorcycles on an annual basis to
determine their corresponding mileage
reimbursement rates. These reviews
evaluate various factors, such as the cost
of fuel, depreciation of the original
vehicle cost, maintenance and
insurance, state and Federal taxes, and
consumer price index data. FTR
Bulletin 20–03 establishes and
announces the new CY 2020 POV
mileage reimbursement rates for official
temporary duty and relocation travel.
This notice is the only notification to
agencies of revisions to the POV mileage
rates for official travel, and relocation,
other than the changes posted on GSA’s
website at https://gsa.gov/mileage.
Jessica Salmoiraghi,
Associate Administrator, Office of
Government-wide Policy.
[FR Doc. 2020–00390 Filed 1–13–20; 8:45 am]
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
BILLING CODE 6820–14–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2020–00372 Filed 1–13–20; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
lotter on DSKBCFDHB2PROD with NOTICES
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
Funding Opportunity Announcement
(FOA), PAR 16–098, Cooperative
Research Agreements to the World
Trade Center Health Program (U01).
Dates: March 10, 2020; and March 11,
2020.
Times: Day One: 8:00 a.m.–5:00 p.m.,
EDT; and Day Two: 8:00 a.m.–12:00
p.m., EDT.
VerDate Sep<11>2014
18:41 Jan 13, 2020
Jkt 250001
Place: Courtyard Marriott Decatur
Downtown/Emory, 130 Clairmont
Avenue, Decatur, Georgia 30030,
Telephone: (404) 371–0204.
Agenda: To review and evaluate grant
applications.
FOR FURTHER INFORMATION CONTACT:
Nina Turner, Ph.D., Scientific Review
Officer, CDC/NIOSH, 1095 Willowdale
Road, Mailstop G905, Morgantown,
West Virginia 26505, Telephone: (304)
285–5975.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–588, CMS–855B
and CMS–R–262]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
SUMMARY:
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected, and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
DATES: Comments on the collection(s) of
information must be received by the
OMB desk officer by February 13, 2020.
ADDRESSES: When commenting on the
proposed information collections,
please reference the document identifier
or OMB control number. To be assured
consideration, comments and
recommendations must be received by
the OMB desk officer via one of the
following transmissions: OMB, Office of
Information and Regulatory Affairs,
Attention: CMS Desk Officer, Fax
Number: (202) 395–5806 OR, Email:
OIRA_submission@omb.eop.gov.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
website address at https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.html.
1. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
2. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires federal agencies
to publish a 30-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension or
reinstatement of an existing collection
of information, before submitting the
collection to OMB for approval. To
comply with this requirement, CMS is
publishing this notice that summarizes
the following proposed collection(s) of
information for public comment:
1. Type of Information Collection
Request: Extension of a currently
E:\FR\FM\14JAN1.SGM
14JAN1
]]>Agencies
[Federal Register Volume 85, Number 9 (Tuesday, January 14, 2020)]
[Notices]
[Page 2136]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-00372]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)--Funding Opportunity Announcement
(FOA), PAR 16-098, Cooperative Research Agreements to the World Trade
Center Health Program (U01).
Dates: March 10, 2020; and March 11, 2020.
Times: Day One: 8:00 a.m.-5:00 p.m., EDT; and Day Two: 8:00 a.m.-
12:00 p.m., EDT.
Place: Courtyard Marriott Decatur Downtown/Emory, 130 Clairmont
Avenue, Decatur, Georgia 30030, Telephone: (404) 371-0204.
Agenda: To review and evaluate grant applications.
FOR FURTHER INFORMATION CONTACT: Nina Turner, Ph.D., Scientific Review
Officer, CDC/NIOSH, 1095 Willowdale Road, Mailstop G905, Morgantown,
West Virginia 26505, Telephone: (304) 285-5975.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-00372 Filed 1-13-20; 8:45 am]
BILLING CODE 4163-18-P
